.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Minocycline hydrochloride - Generic Drug Details

« Back to Dashboard
Minocycline hydrochloride is the generic ingredient in six branded drugs marketed by Impax Labs, Medicis, Zydus Worldwide, Mylan Pharms Inc, Triax Pharms, Sun Pharm Inds, Sun Pharm Inds Ltd, Sandoz, Impax Labs Inc, Lupin Ltd, Par Pharm, Dr Reddys Labs Ltd, Lederle, Rempex Pharms Inc, Precision Dermat, Alkem Labs Ltd, Torrent Pharma Inc, Aurobindo Pharma Ltd, Watson Labs, Cnty Line Pharms, Sun Pharm Inds Inc, Aurobindo Pharma, Orapharma, Barr Labs Inc, and Sidmak Labs India, and is included in thirty-two NDAs. There are thirteen patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

This ingredient has forty patent family members in twenty-two countries.

There are thirteen drug master file entries for minocycline hydrochloride. Forty-six suppliers are listed for this compound. There are six tentative approvals for this compound.

Summary for Generic Name: minocycline hydrochloride

Tradenames:6
Patents:13
Applicants:25
NDAs:32
Drug Master File Entries: see list13
Suppliers / Packaging: see list46
Therapeutic Class:Antibacterials
Dental and Oral Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: minocycline hydrochloride

Ingredient-typeTetracyclines
Drug ClassTetracycline-class Drug

Tentative approvals for MINOCYCLINE HYDROCHLORIDE

Applicant Application No. Form Dosage
<disabled><disabled>TABLET, EXTENDED RELEASE; ORALEQ 65MG BASE
<disabled><disabled>TABLET, EXTENDED RELEASE; ORALEQ 115MG BASE
<disabled><disabled>TABLET, EXTENDED RELEASE; ORALEQ 55MG BASE
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc
MINOCYCLINE HYDROCHLORIDE
minocycline hydrochloride
CAPSULE;ORAL090867-001May 13, 2013RXNo► subscribe► subscribe
Zydus Worldwide
MINOCYCLINE HYDROCHLORIDE
minocycline hydrochloride
CAPSULE;ORAL063009-002Aug 12, 2003RXNo► subscribe► subscribe
Lupin Ltd
MINOCYCLINE HYDROCHLORIDE
minocycline hydrochloride
TABLET, EXTENDED RELEASE;ORAL091424-001Nov 30, 2011RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: minocycline hydrochloride

Country Document Number Estimated Expiration
Canada2479995► subscribe
China101208097► subscribe
World Intellectual Property Organization (WIPO)2010017310► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc